Vimarsana
Biggest News Aggregation in the World

Page 47 - Looking Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Looking Statement Today - Breaking & Trending Today

Starbox Group's StarboxAI - ViPro Module: Transforming Content Creation - Vimarsana News

Starbox Group's StarboxAI - ViPro Module: Transforming Content Creation

Starbox Group's StarboxAI - ViPro Module: Transforming Content Creation

Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa - Vimarsana News

Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa

78% of patients reported that their overall health had improved since starting BioLexa as compared to 22% stating that there was no change in their health, or their health was worse. DLQI found that...

Big Screen Entertainment Group Releases Whitepaper on - Vimarsana News

Big Screen Entertainment Group Releases Whitepaper on

LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Big Screen Entertainment Group (OTC: BSEG), a pioneering production and distribution company, has...

Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference - Vimarsana News

Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

RAHWAY, N.J.--(BUSINESS WIRE)--Sep 5, 2023--

Merck Animal Health Issues Voluntary Recall for Three Lots of BANAMINE® / BANAMINE®-S (Flunixin Meglumine Injection) in the U.S., Due to Presence of Particulate Matter - Vimarsana News

Merck Animal Health Issues Voluntary Recall for Three Lots of BANAMINE® / BANAMINE®-S (Flunixin Meglumine Injection) in the U.S., Due to Presence of Particulate Matter

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is voluntarily recalling three batches of BANAMINE® / BANAMINE®-S (flunixin meglumine injection) 50 mg/mL in the United States, used for injection i

Source: fda.gov